Last updated on July 2019

Long-term Safety Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS

Brief description of study

The purpose of this study is to collect long-term safety, tolerability, effectiveness and health outcomes data in eligible subjects who have participated in a Novartis ofatumumab clinical MS study.

Clinical Study Identifier: NCT03650114

Find a site near you

Start Over

Novartis Investigative Site

Lille Cedex, France
  Connect »